Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study of the Effects of Vaginal Testosterone Therapy

INTRODUCTION: Women with breast cancer have better cancer-related outcomes with the use of aromatase inhibitors (AIs), but the physiological suppression of estradiol can negatively affect sexual functioning because of unpleasant urogenital and vaginal symptoms. Local health care practitioners have o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahir, Melissa, Travers-Gustafson, Dianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Research—Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184610/
https://www.ncbi.nlm.nih.gov/pubmed/25356296
http://dx.doi.org/10.1002/sm2.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184610/
https://www.ncbi.nlm.nih.gov/pubmed/25356296
http://dx.doi.org/10.1002/sm2.22

Ejemplares similares